Effect of the Faradarmani Consciousness Field on Mutant Strain of SARS-CoV-2

The COVID-19 pandemic is still a threat to global health. In late 2020, the rapid emergence of SARS-CoV-2 mutant strains was reported, raising concerns in the prevention and treatment of COVID-19. SARS-CoV-2 carrying the D614G mutation in the viral spike (S) protein predominated globally, and this change increased virus transmission. Furthermore, false-negative results in respiratory specimens are a problem in COVID-19 detection. Taheri Consciousness Fields (TCFs) introduced by Mohammad Ali Taheri are novel fields that neither matter nor energy. Therefore, they are not quantifiable and cannot be directly observed or measured. However, it is possible to demonstrate and measure the effects of these fields through standard scientific experiments. The present study aimed to evaluate the effect of Faradarmani CF, one of the TCFs, on the titer and RNA copy number of the mutant D614G virus and on the quality of amplification of coronavirus genome fragments. The results of this study showed that Faradarmani CF increased the replication of both non-mutated and mutated viruses compared with the control, thereby improving their replication fitness. The Faradarmani CF increased the rate of replication of the mutant strain in cells to a level close to that of the non-mutant strain, and, in fact, reached a biological equilibrium of compatibility similar to that of the Wuhan strain with the cells. The study suggests that Faradarmani CF acted as a modulator, equalizing replication rates between mutant and non-mutant strains, thereby achieving a biological equilibrium akin to the Wuhan strain. Scientifically, this is provocative; it challenges conventional molecular biology and demands rigorous studies. In addition, the PCR products of coronavirus genome fragments under the influence of the Faradarmani CF showed sharper bands on gel electrophoresis and higher-quality amplification compared with the control. This result suggests that Faradarmani CF can be used in diagnostic assays to reduce false-negative results and improve test sensitivity. Based on the results, it is recommended that the effects of TCFs on other mutants be investigated.